JPM vs MNSB

JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.

MNSB presents a classic value trap profile with a stable Piotroski F-Score of 4/9 and a Graham Number of $32.32 suggesting significant defensive undervaluation. While the stock trades at a discount to book value (P/B 0.88) and shows strong top-line revenue growth of 31.8%, this is offset by a dismal earnings track record with zero beats in the last four quarters. The stark divergence between the Graham Number ($32.32) and the growth-based Intrinsic Value ($12.32) indicates that while assets are undervalued, the earning power is weak. Technical trends are heavily bearish (10/100), suggesting the market is pricing in these fundamental earnings struggles.